BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Esposito I, Konukiewitz B, Schlitter AM, Klöppel G. Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments. World J Gastroenterol 2014; 20(38): 13833-13841 [PMID: 25320520 DOI: 10.3748/wjg.v20.i38.13833]
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13833.htm
Number Citing Articles
1
Přemysl Frič, Jan Škrha, Aleksi Šedo, Petr Bušek, Martin Laclav, Bohuš Bunganič, Miroslav Zavoral. Precursors of pancreatic cancerEuropean Journal of Gastroenterology & Hepatology 2017; 29(3): e13 doi: 10.1097/MEG.0000000000000810
2
Kelly E. Diaz, Aimee L. Lucas. Familial Pancreatic Ductal AdenocarcinomaThe American Journal of Pathology 2019; 189(1): 36 doi: 10.1016/j.ajpath.2018.06.026
3
Haidi Chen, Qifeng Zhuo, Zeng Ye, Xiaowu Xu, Shunrong Ji. Organoid model: A new hope for pancreatic cancer treatment?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1875(1): 188466 doi: 10.1016/j.bbcan.2020.188466
4
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overviewInternational Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
5
Ari Kassardjian, Nicholas Stanzione, Hanlin L. Wang. Comparative Accuracy of Tumor Size Assessment and Stage Analysis by Imaging Modalities Versus Gross Examination for Pancreatic Ductal AdenocarcinomaPancreas 2019; 48(2): 223 doi: 10.1097/MPA.0000000000001233
6
Paul J. Kelly. Histopathology Reporting2020; : 55 doi: 10.1007/978-3-030-27828-1_4
7
Mark J. Hoenerhoff, Arun Kumar R. Pandiri. Toxicologic Pathology for Non-Pathologists2019; : 137 doi: 10.1007/978-1-4939-9777-0_5
8
John C. Chang, Madappa Kundranda. Novel Diagnostic and Predictive Biomarkers in Pancreatic AdenocarcinomaInternational Journal of Molecular Sciences 2017; 18(3): 667 doi: 10.3390/ijms18030667
9
Björn Konukiewitz, Moritz Jesinghaus, Atsuko Kasajima, Günter Klöppel. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfallsVirchows Archiv 2021;  doi: 10.1007/s00428-021-03211-5
10
Sang Hyun Choi, Hyoung Jung Kim, Kyung Won Kim, Soyeon An, Seung-Mo Hong, Song Cheol Kim, Myung-Hwan Kim. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristicsThe British Journal of Radiology 2017; 90(1073): 20160403 doi: 10.1259/bjr.20160403
11
Khadija El Jellas, Dag Hoem, Kristin G Hagen, May Britt Kalvenes, Sura Aziz, Solrun J Steine, Heike Immervoll, Stefan Johansson, Anders Molven. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survivalCancer Medicine 2017; 6(7): 1531 doi: 10.1002/cam4.1097
12
Chanjuan Shi, Fong Cheng Pan, Jessica N. Kim, M. Kay Washington, Chandrasekhar Padmanabhan, Christian T. Meyer, Janel L. Kopp, Maike Sander, Maureen Gannon, R. Daniel Beauchamp, Christopher V. Wright, Anna L. Means. Differential Cell Susceptibilities to Kras in the Setting of Obstructive Chronic PancreatitisCellular and Molecular Gastroenterology and Hepatology 2019; 8(4): 579 doi: 10.1016/j.jcmgh.2019.07.001
13
Vimal Arora, Dinesh Kumar Chellappan, Krishnan Anand, Harish Dureja. Advanced Drug Delivery Systems in the Management of Cancer2021; : 243 doi: 10.1016/B978-0-323-85503-7.00030-4
14
Guillermo Urrutia, Thiago Milech de Assuncao, Angela J. Mathison, Ann Salmonson, Romica Kerketta, Atefeh Zeighami, Timothy J. Stodola, Volkan Adsay, Burcin Pehlivanoglu, Michael B. Dwinell, Michael T. Zimmermann, Juan L. Iovanna, Raul Urrutia, Gwen Lomberk. Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression NetworksFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.681153
15
Günter Klöppel, Irene Esposito, Atsuko Kasajima, Björn Konukiewitz, Jutta Lüttges, Bence Sipos. PathologiePathologie 2020; : 707 doi: 10.1007/978-3-642-04557-8_24
16
M. Ducreux, A. Sa. Cuhna, C. Caramella, A. Hollebecque, P. Burtin, D. Goéré, T. Seufferlein, K. Haustermans, J.L. Van Laethem, T. Conroy, D. Arnold. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology 2015; 26: v56 doi: 10.1093/annonc/mdv295
17
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsWorld Journal of Gastroenterology 2016; 22(9): 2678-2700 doi: 10.3748/wjg.v22.i9.2678
18
Götz M. Richter. Pancreatic Cancer2018; : 681 doi: 10.1007/978-1-4939-7193-0_90
19
Anna Melissa Schlitter, Björn Konukiewitz, Atsuko Kasajima, Maximilian Reichert, Günter Klöppel. Das duktale Adenokarzinom des Pankreas: Subtypen und MolekularpathologieDer Pathologe 2021; 42(5): 464 doi: 10.1007/s00292-021-00965-2
20
Anna Melissa Schlitter, Angela Segler, Katja Steiger, Christoph W. Michalski, Carsten Jäger, Björn Konukiewitz, Nicole Pfarr, Volker Endris, Markus Bettstetter, Bo Kong, Ivonne Regel, Jörg Kleeff, Günter Klöppel, Irene Esposito. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypesScientific Reports 2017; 7(1) doi: 10.1038/srep41064
21
Rita Rebelo, Bárbara Polónia, Lúcio Lara Santos, M. Helena Vasconcelos, Cristina P. R. Xavier. Drug Repurposing Opportunities in Pancreatic Ductal AdenocarcinomaPharmaceuticals 2021; 14(3): 280 doi: 10.3390/ph14030280
22
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of PathologyEncyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5574-1
23
Götz M. Richter. Pancreatic Cancer2018; : 1 doi: 10.1007/978-1-4939-6631-8_90-1
24
Zhaoyan Qiu, Yi Chu, Bing Xu, Qian Wang, Mingzuo Jiang, Xiaowei Li, Gang Wang, Pengfei Yu, Guoxiao Liu, Hua Wang, Huijie Kang, Jiayu Liu, Yu Zhang, Jian-Ping Jin, Kaichun Wu, Jie Liang. Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinomaOncotarget 2017; 8(34): 56428 doi: 10.18632/oncotarget.17701
25
Yusuke Fujita, Minoru Kitago, Yohei Masugi, Osamu Itano, Masahiro Shinoda, Yuta Abe, Taizo Hibi, Hiroshi Yagi, Yoko Fujii-Nishimura, Michiie Sakamoto, Yuko Kitagawa. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasisWorld Journal of Gastroenterology 2016; 22(41): 9222-9228 doi: 10.3748/wjg.v22.i41.9222
26
Jia Yao, Man Yang, Lawrence Atteh, Pinyan Liu, Yongcui Mao, Wenbo Meng, Xun Li. A pancreas tumor derived organoid study: from drug screen to precision medicineCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02044-1
27
Sukhwinder Kaur, Maneesh Jain, Surinder K. Batra. Liquid Biopsy for Identification of High-Risk Cystic Lesions of PancreasGastroenterology 2021; 160(4): 1016 doi: 10.1053/j.gastro.2020.12.039
28
Tobias Piegeler, Thomas Winder, Sabine Kern, Bernhard Pestalozzi, Paul Magnus Schneider, Beatrice Beck-Schimmer. Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch® system: An observational feasibility studyOncology Letters 2016; 12(2): 1513 doi: 10.3892/ol.2016.4809
29
Linying Chen, Xiao Xu, Xinxin Wen, Shenmin Xu, Long Wang, Wenxian Lu, Mingting Jiang, Jing Huang, Dayun Yang, Jichuang Wang, Min Zheng, Xiao Zhen Zhou, Kun Ping Lu, Hekun Liu. Targeting PIN 1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis Cancer Science 2019; 110(8): 2442 doi: 10.1111/cas.14085
30
Linning E, Yan Xu, Zhifeng Wu, Li Li, Na Zhang, Hao Yang, Lawrence H. Schwartz, Lin Lu, Binsheng Zhao. Differentiation of Focal-Type Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma Using Radiomics Based on Multiphasic Computed TomographyJournal of Computer Assisted Tomography 2020; 44(4): 511 doi: 10.1097/RCT.0000000000001049
31
Qi Zhou, Xufeng Tao, Shilin Xia, Fangyue Guo, Chen Pan, Hong Xiang, Dong Shang. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00382
32
Leticia Moreira, Basil Bakir, Priya Chatterji, Zahra Dantes, Maximilian Reichert, Anil K. Rustgi. Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic CancerCellular and Molecular Gastroenterology and Hepatology 2018; 5(3): 289 doi: 10.1016/j.jcmgh.2017.12.004
33
Enrica Saponara, Michele Visentin, Francesco Baschieri, Gitta Seleznik, Paola Martinelli, Irene Esposito, Johanna Buschmann, Rong Chen, Rossella Parrotta, Nathalie Borgeaud, Marta Bombardo, Ermanno Malagola, Amedeo Caflisch, Hesso Farhan, Rolf Graf, Sabrina Sonda. Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreasThe Journal of Pathology 2018; 246(3): 352 doi: 10.1002/path.5147
34
Joseph Carmicheal, Asish Patel, Vipin Dalal, Pranita Atri, Amaninder S. Dhaliwal, Uwe A. Wittel, Mokenge P. Malafa, Geoffrey Talmon, Benjamin J. Swanson, Shailender Singh, Maneesh Jain, Sukhwinder Kaur, Surinder K. Batra. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188318 doi: 10.1016/j.bbcan.2019.188318
35
Mirella Giordano, Andrea Cacciato Insilla, Daniela Campani. Encyclopedia of PathologyEncyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5533-1
36
Anusha Ande, Maher Chaar, Sihem Ait-Oudhia. Multiscale systems pharmacological analysis of everolimus action in hepatocellular carcinomaJournal of Pharmacokinetics and Pharmacodynamics 2018; 45(4): 607 doi: 10.1007/s10928-018-9590-0
37
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomesWorld Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
38
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of PathologyEncyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5572-1
39
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of PathologyEncyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5573-1
40
Marta Cáceres, Rita Quesada, Mar Iglesias, Francisco X. Real, Maria Villamonte, Jaime Martinez de Villarreal, Mónica Pérez, Ana Andaluz, Xavier Moll, Enrique Berjano, Dimitri Dorcaratto, Patricia Sánchez-Velázquez, Luís Grande, Fernando Burdío. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-74947-4
41
Aditi Kothari, Matthew J. Flick. Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal AdenocarcinomaInternational Journal of Molecular Sciences 2021; 22(10): 5138 doi: 10.3390/ijms22105138
42
Jonghyeob Lee, Emily R. Snyder, Yinghua Liu, Xueying Gu, Jing Wang, Brittany M. Flowers, Yoo Jung Kim, Sangbin Park, Gregory L. Szot, Ralph H. Hruban, Teri A. Longacre, Seung K. Kim. Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cellsNature Communications 2017; 8(1) doi: 10.1038/ncomms14686
43
Na Li, Fan Yang, Dong-Yan Liu, Jin-Tao Guo, Nan Ge, Si-Yu Sun. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathwayWorld Journal of Gastrointestinal Oncology 2021; 13(9): 1164-1183 doi: 10.4251/wjgo.v13.i9.1164